SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-255964
Filing Date
2019-09-26
Accepted
2019-09-26 16:14:51
Documents
78
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 6-K d799263d6k.htm 6-K 13362
2 EX-99.1 d799263dex991.htm EX-99.1 713693
9 GRAPHIC g799263dsp123.jpg GRAPHIC 1223
10 GRAPHIC g799263g49t31.jpg GRAPHIC 18513
11 GRAPHIC g799263g55s48.jpg GRAPHIC 10470
12 GRAPHIC g799263g76v23.jpg GRAPHIC 1912
  Complete submission text file 0001193125-19-255964.txt   7133056

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE DOCUMENT eryp-20190630.xml EX-101.INS 1949728
4 XBRL TAXONOMY EXTENSION SCHEMA eryp-20190630.xsd EX-101.SCH 103247
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eryp-20190630_cal.xml EX-101.CAL 92070
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eryp-20190630_def.xml EX-101.DEF 277100
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE eryp-20190630_lab.xml EX-101.LAB 580909
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eryp-20190630_pre.xml EX-101.PRE 424923
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 191118043
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences